首页 | 本学科首页   官方微博 | 高级检索  
     

Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells
引用本文:Cao Q,Lu X,Feng YJ. Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells[J]. Cell research, 2006, 16(7): 671-677
作者姓名:Cao Q  Lu X  Feng YJ
作者单位:Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China
基金项目:Acknowledgments We thank Dr Y Rao (Northwestem University) for generously providing Axin GID5-6/pCS2MT, Axin GID5- 6LP/pCS2MT and GSK-313 S9A/pCS2 plasmids and YC Jia, CX Huang, Y Hou for critical discussion and ZJ Fan for technical support. This work was supported by Grant from Shanghai Foundation for Key Subject Development of Medical Science (05111016).
摘    要:Although glycogen synthase kinase-3 (GSK-3) might act as a tumor suppressor since its inhibition is expected to mimic the activation of Wnt-signaling pathway, GSK-3β may contribute to NF-κB activation in cancer cells leading to increased cancer cell proliferation and survival. Here we report that GSK-3β activity was involved in the proliferation of human ovarian cancer cell both in vitro and in vivo. Inhibition of GSK-3 activity by pharmacological inhibitors suppressed proliferation of the ovarian cancer cells. Overexpressing constitutively active form of GSK-3β induced entry into the S phase, increased cyclin D1 expression and facilitated the proliferation of ovarian cancer cells. Furthermore, GSK-3 inhibition prevented the formation of the tumor in nude mice generated by the inoculation of human ovarian cancer cells. Our findings thus suggest that GSK-3β activity is important for the proliferation of ovarian cancer cells, implicating this kinase as a potential therapeutic target in ovarian cancer.

关 键 词:糖原合酶激酶-3β 酶活性 卵巢肿瘤 肿瘤细胞
收稿时间:2005-12-15
修稿时间:2005-12-152006-04-24

Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells
Cao Qi,Lu Xin,Feng You-Ji. Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells[J]. Cell research, 2006, 16(7): 671-677
Authors:Cao Qi  Lu Xin  Feng You-Ji
Affiliation:Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China.
Abstract:Although glycogen synthase kinase-3 (GSK-3) might act as a tumor suppressor since its inhibition is expected to mimic the activation of Wnt-signaling pathway, GSK-3beta may contribute to NF-kappaB activation in cancer cells leading to increased cancer cell proliferation and survival. Here we report that GSK-3beta activity was involved in the proliferation of human ovarian cancer cell both in vitro and in vivo. Inhibition of GSK-3 activity by pharmacological inhibitors suppressed proliferation of the ovarian cancer cells. Overexpressing constitutively active form of GSK-3beta induced entry into the S phase, increased cyclin D1 expression and facilitated the proliferation of ovarian cancer cells. Furthermore, GSK-3 inhibition prevented the formation of the tumor in nude mice generated by the inoculation of human ovarian cancer cells. Our findings thus suggest that GSK-3beta activity is important for the proliferation of ovarian cancer cells, implicating this kinase as a potential therapeutic target in ovarian cancer.
Keywords:
本文献已被 CNKI 维普 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号